SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Sold by U.S. Capital Wealth Advisors LLC

U.S. Capital Wealth Advisors LLC lessened its holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 11.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,710 shares of the company’s stock after selling 2,620 shares during the period. U.S. Capital Wealth Advisors LLC owned approximately 0.41% of SPDR S&P Pharmaceuticals ETF worth $847,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. AlphaMark Advisors LLC raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 5.9% in the 3rd quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after buying an additional 348 shares during the period. First Citizens Bank & Trust Co. raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.5% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock valued at $3,196,000 after buying an additional 6,227 shares during the period. BNP Paribas Financial Markets raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 208.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock valued at $6,628,000 after buying an additional 101,000 shares during the period. Stifel Financial Corp purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $337,000. Finally, JPMorgan Chase & Co. raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 36.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock valued at $197,000 after buying an additional 1,182 shares during the period.

SPDR S&P Pharmaceuticals ETF Price Performance

Shares of NYSEARCA XPH opened at $45.07 on Wednesday. The stock’s 50-day moving average is $44.35 and its two-hundred day moving average is $44.45. SPDR S&P Pharmaceuticals ETF has a 1-year low of $38.88 and a 1-year high of $48.76. The company has a market cap of $218.59 million, a price-to-earnings ratio of 14.39 and a beta of 0.87.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.